We are a PARENT-LED organization on MISSION to change the lives of ALL struggling Frizzle patients around the world!

We developed a GENE THERAPY DRUG for Frizzle Disease. Learn more HOW YOU CAN HELP fund a future clinical trial!

QUICK INFO & LINKS

WHY THIS MATTERS 

CHANGE LIVES and CHANGE the WORLD for ALL NEURO DISEASE.

Finding Hope for Frizzle (FRRS1L) is a parent-led, Colorado registered 501c3 nonprofit organization, dedicated to developing life-changing treatment for children living with FRRS1L (pronounced Frizzle) genetic disease. The organization leads a comprehensive therapeutic development program spanning scientific research, regulatory strategy, manufacturing, clinical development, and patient advocacy, with the mission of bringing an effective gene replacement therapy treatment to patients as quickly as possible while helping advance the future of all neuro disease drug development. The organization has no paid staff and all donated dollars go to directly fund an upcoming FRRS1L clinical trial.

Finding Hope for Frizzle has licensed the new TfR1 CapX capsid technology. The collaboration marks a major milestone not only for families affected by Frizzle disease, but also for the future of gene therapy. The clinical program will utilize the innovative TfR1 CapX capsid, a next-generation AAV delivery platform designed to improve distribution of gene therapies throughout the brain following an intravenous (IV) infusion.

While a trial woud be focused on treating children with Frizzle disease, the implications with this therapeutic capsid extend far beyond a single rare disease. It has the potential to change gene therapy delivery for all neurological disease such as Alzheimer's and Parkinson’s disease. The successful clinical application of TfR1 CapX has the potential to accelerate the development of gene therapies for numerous neurological disorders by demonstrating a more efficient method of delivering genetic medicines throughout the central nervous system. If successful, the knowledge gained through this program could help shape the future of gene therapy for patients around the world. Learn more here.

WE NEED YOUR HELP!

A sign encouraging donations to fund treatment for Frizzle patients, with text in various shades of blue and green and a heart icon.

It wasn't always like this for children with FRRS1L gene disorder.

Before the disorder took full effect, parents knew and saw their children to be busy toddlers. FRRS1L is a critical brain encoding gene that affects all cells in the brain. Children with this gene disorder develop, albeit delayed, until age two when they begin having seizural activity that causes regression and total loss of function.

Learn more about FRRS1L